The AtaCor EV Temporary Pacing System

AN INSIDE JOB

THAT’S OUTSIDE THE HEART.

First of its kind, the innovative AtaCor EV Temporary Pacing Lead System is advancing the standard of cardiac pacing. It is the only implantable temporary pacing system being designed to leave the heart and vascular system completely untouched—for prompt pacing support without the discomfort, risk, and limitations of traditional methods.

Product

Extravascular. Extracardiac. Extraordinary.

The custom StealthTrac Lead connects to commercially-available external pacemakers.

Using a proprietary parasternal approach, the AtaCor EV Temporary Pacing Lead System advances a custom pacing lead into the extracardiac tissue between the ribs and pericardium. The extravascular lead location avoids risks specific to transvenous leads:

Valvular Interference and Lead Dislodgement

Temporary pacing beyond the cath lab

and beyond expectations.

Imaging-free delivery is being designed to get the heart up to speed without slowing you down. With the AtaCor EV Temporary Pacing Lead System, lead delivery will no longer rely on fluoroscopic guidance or cath lab availability, reducing time-to-therapy and enabling you to provide hassle-free pacing protection at the speed of life.

TIMELY PROTECTION

WITHOUT THE DISCOMFORT.

Unlike traditional pacing methods, the AtaCor EV Temporary Pacing Lead System is being designed to rapidly and reliably restore cardiac rhythm with patient comfort in mind, eliminating patient discomfort from jugular or femoral vein access for transvenous pacing and enabling emergent pacing without stimulating skeletal muscle.

EXTRAVASCULAR ACCESS FOR

REDUCED BEDREST RESTRICTIONS.

In addition to streamlining delivery of temporary pacing, the AtaCor EV Temporary Pacing Lead System’s extravascular implantation is being designed to remove bedrest restrictions, speeding patient recovery, and shortening hospital length-of-stay:

Supports safe post-procedure patient ambulation
Enables patient transfer to non-ICU bed for extended evaluation
Reduces need for ICU observation and related nursing resources, decreasing cost-of-care

SIMPLIFYING PATIENT MANAGEMENT

DURING AND AFTER TAVI

TAVI procedures are on the rise—and expected to increase as the population ages and procedure indications expand to younger and healthier patients.¹ The AtaCor EV Temporary Pacing Lead System is being designed to support stable extravascular and extracardiac pacing during valve deployment and postoperative evaluation for conduction disturbances, for streamlined TAVI patient management and recovery:

Enables preoperative lead insertion which may shorten overall procedure length
Connects to commercially-available external temporary pacemakers
Eliminates transvenous pacing leads
Reduces vascular access management and complications
Enables safe post-procedure patient ambulation
Eliminates bedrest restrictions, reducing ICU and related nursing costs

SIMPLIFYING PATIENT MANAGEMENT

AFTER MYOCARDIAL INFARCTION

Conduction abnormalities, whether transitory or persistent, develop in approximately 90% of patients who experience a myocardial infarction.² The AtaCor EV Temporary Pacing Lead System is being designed to support stable pacing of new-onset arrhythmias to help guide treatment decisions and optimize patient care:

Enables evaluation of conduction disturbances to determine the need for permanent pacing
Enables safe post-procedure patient ambulation
Eliminates bedrest restrictions, reducing ICU and related nursing costs

Carroll JD. TAVR prognosis, aging, and the second TAVR tsunami: insights from France. J Am Coll Cardiol. 2016;68(15):1648-50.
Perron AD, Sweeney T. Arrhythmic complications of acute coronary syndromes. Emerg Med Clin North Am. 2005;23(4):1065-1082.

ENGINEERED WITH THE

HUMAN ANATOMY IN MIND.

Deliberate design features built directly into the AtaCor EV Temporary Pacing Lead System are intended to complement the cardiothoracic anatomy for precise pacing protection that preserves patients’ vasculature.

AtaCor EV Temporary Pacing System